SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-13-000086
Filing Date
2013-11-07
Accepted
2013-11-07 17:23:11
Documents
13
Period of Report
2013-11-04

Document Format Files

Seq Description Document Type Size
1 10-Q quarterly_report-093013.htm 10-Q 812769
2 ROGERS, MICHAEL OFFER LETTER exhibit_10-1.htm EX-10.1 25828
3 CEO CERTIFICATION exhibit_31-1.htm EX-31.1 15610
4 CFO CERTIFICATION exhibit_31-2.htm EX-31.2 15602
5 CEO CERTIFICATION exhibit_32-1.htm EX-32.1 6907
6 CFO CERTIFICATION exhibit_32-2.htm EX-32.2 7018
13 ACORDA LOGO acorda_logo-bw.jpg GRAPHIC 4764
  Complete submission text file 0001008848-13-000086.txt   7553079

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acor-20130930.xml EX-101.INS 828055
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20130930.xsd EX-101.SCH 82663
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20130930_cal.xml EX-101.CAL 66254
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20130930_def.xml EX-101.DEF 433889
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20130930_lab.xml EX-101.LAB 1461981
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20130930_pre.xml EX-101.PRE 681561
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 131201790
SIC: 2836 Biological Products, (No Diagnostic Substances)